Select Biosciences Ltd

Webcasts

Complicity Complications in Induced Pluripotent Stem Cell Research
18 July 2010
Mark Brown, Professor, University of Wisconsin, Speaking at Stem Cells World Congress 2010.

The Promise of Stem Cells as a Neuroregenerative Approach to the Treatment of Multiple Sclerosis (MS)
07 July 2010
Claude Bernard, Professor of Neuroimmunology and Associate Director, MISCL, Monash University, Speaking At Stem Cells World Congress 2010.

Development of the Multi-Stage Stem Cell Carcinogenesis (MSCC) Model/Drug Discovery Platform
23 February 2010
Ana Krtolica, Chief Scientific Officer, SLL Sciences, speaking at Stemcells World Congress 2010

IP Update: Patentability of Stem Cell Inventions in Europe
19 June 2009
Nick Bassil, Patent Attorney, Kilburn & Strode, speaking at the Stem Cells World Congress 2008

Patentability of Embroynic Stem Cells
19 June 2009
Philippa Montgomerie, Associate, DLA Piper Scotland, speaking at the Stem Cells World Congress 2008

Terms of Engagement: Knowledge Transfer Between Industry and Academia
19 June 2009
Jolyon White, Technology Consultant, London Technology Network, speaking at the Stem Cells World Congress 2008

Building an hES Cell Screening Capability: Fast Track to Cell Production
18 June 2009
Fergus McKenzie, Programme Manager, ITI Life Sciences, speaking at the Stem Cells World Congress 2008

Cardiovascular Cell Therapy with Human Mesenchymal Stem Cells: New Molecules with Differentiating and Paracrine Logics
18 June 2009
Carlo Ventura, Professor of Molecular Biology, Laboratory of Molecular Biology and Stem Cell Engineering, University of Bologna, speaking at the Stem Cells World Congress 2008